These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation. Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374 [TBL] [Abstract][Full Text] [Related]
4. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies. Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364 [TBL] [Abstract][Full Text] [Related]
5. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience. Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918 [TBL] [Abstract][Full Text] [Related]
6. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377 [TBL] [Abstract][Full Text] [Related]
7. Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report. Lococo F; Di Giorgio A; Iaffaldano A; Schinzari G; Tabacco D; Aceto P; Abatini C; Sollazzi L; Margaritora S Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):362-365. PubMed ID: 33506925 [TBL] [Abstract][Full Text] [Related]
8. Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature. Ostoros G; Pretz A; Fillinger J; Soltesz I; Dome B Int J Gynecol Cancer; 2006; 16 Suppl 1():391-3. PubMed ID: 16515630 [TBL] [Abstract][Full Text] [Related]
16. Incidence of interstitial pneumonitis in non-Hodgkin's lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab. Zhou T; Shen Q; Peng H; Chao T; Zhang L; Huang L; Yang K; Thapa S; Yu S; Jiang Y Ann Hematol; 2018 Jan; 97(1):141-147. PubMed ID: 29086009 [TBL] [Abstract][Full Text] [Related]
17. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin. de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057 [TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients. Usui K; Katou Y; Furushima K; Tanaka Y; Tanai C; Ishihara T Jpn J Clin Oncol; 2011 Apr; 41(4):498-502. PubMed ID: 21303791 [TBL] [Abstract][Full Text] [Related]
19. A new device for the treatment of pleural malignancies: intrapleural chemohyperthermia preliminary report. Carry PY; Brachet A; Gilly FN; Sayag AC; Petit PY; Rochette C; Mulsant P; Guibert B; Braillon G; Banssillon V Oncology; 1993; 50(5):348-52. PubMed ID: 8378029 [TBL] [Abstract][Full Text] [Related]
20. Hyperthermic pleural perfusion with cisplatin: early clinical experience. Yellin A; Simansky DA; Paley M; Refaely Y Cancer; 2001 Oct; 92(8):2197-203. PubMed ID: 11596038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]